While taking hormonal birth control -- whether orally or through an IUD -- may raise the risk of breast cancer, the risk is ...

Freeda, a 20-foot inflatable intrauterine device [IUD], visited the Decatur Square on Friday, Oct. 18, as state leaders advocated for maintaining access to contraception.

During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a ...

On Monday, Hologic Inc (NASDAQ:HOLX) agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a ...

Women who use a contraceptive coil may be at a slightly higher risk of breast cancer, new research suggests. The hormonal ...

See related article at KEY POINTS Early pregnancy loss is common and often devastating. Adverse medical and psychological complications may be avoided with the provision of informed, compassionate ...

The study found an 'unexpected' association between the use of an intrauterine system, also known as an hormonal coil, and an ...

Iowa is under a near-total abortion ban, and Democratic challenger Lanon Baccam is trying to make it US Rep. Zach Nunn’s ...

Gynesonics pioneered and launched the Sonata System, the first FDA-cleared medical device for diagnostic intrauterine imaging ...

A new study adds to the evidence on hormonal contraceptives and breast cancer. But experts stressed the overall risk remains ...

Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.

Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a ...